Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas

Masaya Takeda, Fumio Otsuka, Jiro Suzuki, Masayuki Kishida, Toshio Ogura, Takashi Tamiya, Hirofumi Makino

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Roles of activin/bone morphogenetic protein (BMP) system in the pathogenesis of human pituitary adenoma remain unknown although these factors stimulate follicle-stimulating hormone (FSH) secretion in the normal pituitary. Here we demonstrated that type-I and -II subunit mRNAs of activin/BMP receptors are expressed in Pit-1-negative FSH-producing (FSH-oma) and nonfunctioning pituitary adenomas (NF-oma). Basal levels of serum FSH standardized by luteinizing hormone (LH) were markedly high in FSH-omas in contrast to NF-omas. However, gonadotropin-releasing hormone (GnRH)-induced increment of FSH standardized by that of LH was not changed in FSH-omas, suggesting that imbalanced FSH secretion by FSH-oma is not attributable to GnRH regardless of the expression of GnRH receptor. Although activin βA subunit was detected in neither adenoma, the βB subunit was expressed highly in FSH-omas and, to lesser extent, in NF-omas. As for BMPs, BMP-6 and -7 were detected in NF-omas while BMP-4 and -15 were not detected in either type of adenoma. In the presence of pituitary activin/BMP system, the levels of co-expressing follistatin mRNA in the tumors were reduced in FSH-oma compared with NF-oma, suggesting that endogenous follistatin is involved in FSH overproduction through inhibition of activin/BMP system independently of GnRH.

Original languageEnglish
Pages (from-to)812-818
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume306
Issue number4
DOIs
Publication statusPublished - Jul 11 2003

Fingerprint

Activins
Bone Morphogenetic Proteins
Follicle Stimulating Hormone
Human Development
Adenoma
Gonadotropin-Releasing Hormone
Follistatin
Pituitary Neoplasms
Luteinizing Hormone
Bone Morphogenetic Protein 15
Bone Morphogenetic Protein 6
Bone Morphogenetic Protein Receptors
Bone Morphogenetic Protein 4
Bone Morphogenetic Protein 7
LHRH Receptors
Messenger RNA
Tumors

Keywords

  • Activin
  • Bone morphogenetic protein
  • Follicle-stimulating hormone
  • Follistatin
  • Gonadotropin-releasing hormone
  • Gonadotropinoma
  • Luteinizing hormone
  • Macroadenoma
  • Pituitary adenoma

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas. / Takeda, Masaya; Otsuka, Fumio; Suzuki, Jiro; Kishida, Masayuki; Ogura, Toshio; Tamiya, Takashi; Makino, Hirofumi.

In: Biochemical and Biophysical Research Communications, Vol. 306, No. 4, 11.07.2003, p. 812-818.

Research output: Contribution to journalArticle

@article{447d1edad0d948fdabc18df1a1c61cf5,
title = "Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas",
abstract = "Roles of activin/bone morphogenetic protein (BMP) system in the pathogenesis of human pituitary adenoma remain unknown although these factors stimulate follicle-stimulating hormone (FSH) secretion in the normal pituitary. Here we demonstrated that type-I and -II subunit mRNAs of activin/BMP receptors are expressed in Pit-1-negative FSH-producing (FSH-oma) and nonfunctioning pituitary adenomas (NF-oma). Basal levels of serum FSH standardized by luteinizing hormone (LH) were markedly high in FSH-omas in contrast to NF-omas. However, gonadotropin-releasing hormone (GnRH)-induced increment of FSH standardized by that of LH was not changed in FSH-omas, suggesting that imbalanced FSH secretion by FSH-oma is not attributable to GnRH regardless of the expression of GnRH receptor. Although activin βA subunit was detected in neither adenoma, the βB subunit was expressed highly in FSH-omas and, to lesser extent, in NF-omas. As for BMPs, BMP-6 and -7 were detected in NF-omas while BMP-4 and -15 were not detected in either type of adenoma. In the presence of pituitary activin/BMP system, the levels of co-expressing follistatin mRNA in the tumors were reduced in FSH-oma compared with NF-oma, suggesting that endogenous follistatin is involved in FSH overproduction through inhibition of activin/BMP system independently of GnRH.",
keywords = "Activin, Bone morphogenetic protein, Follicle-stimulating hormone, Follistatin, Gonadotropin-releasing hormone, Gonadotropinoma, Luteinizing hormone, Macroadenoma, Pituitary adenoma",
author = "Masaya Takeda and Fumio Otsuka and Jiro Suzuki and Masayuki Kishida and Toshio Ogura and Takashi Tamiya and Hirofumi Makino",
year = "2003",
month = "7",
day = "11",
doi = "10.1016/S0006-291X(03)01052-0",
language = "English",
volume = "306",
pages = "812--818",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas

AU - Takeda, Masaya

AU - Otsuka, Fumio

AU - Suzuki, Jiro

AU - Kishida, Masayuki

AU - Ogura, Toshio

AU - Tamiya, Takashi

AU - Makino, Hirofumi

PY - 2003/7/11

Y1 - 2003/7/11

N2 - Roles of activin/bone morphogenetic protein (BMP) system in the pathogenesis of human pituitary adenoma remain unknown although these factors stimulate follicle-stimulating hormone (FSH) secretion in the normal pituitary. Here we demonstrated that type-I and -II subunit mRNAs of activin/BMP receptors are expressed in Pit-1-negative FSH-producing (FSH-oma) and nonfunctioning pituitary adenomas (NF-oma). Basal levels of serum FSH standardized by luteinizing hormone (LH) were markedly high in FSH-omas in contrast to NF-omas. However, gonadotropin-releasing hormone (GnRH)-induced increment of FSH standardized by that of LH was not changed in FSH-omas, suggesting that imbalanced FSH secretion by FSH-oma is not attributable to GnRH regardless of the expression of GnRH receptor. Although activin βA subunit was detected in neither adenoma, the βB subunit was expressed highly in FSH-omas and, to lesser extent, in NF-omas. As for BMPs, BMP-6 and -7 were detected in NF-omas while BMP-4 and -15 were not detected in either type of adenoma. In the presence of pituitary activin/BMP system, the levels of co-expressing follistatin mRNA in the tumors were reduced in FSH-oma compared with NF-oma, suggesting that endogenous follistatin is involved in FSH overproduction through inhibition of activin/BMP system independently of GnRH.

AB - Roles of activin/bone morphogenetic protein (BMP) system in the pathogenesis of human pituitary adenoma remain unknown although these factors stimulate follicle-stimulating hormone (FSH) secretion in the normal pituitary. Here we demonstrated that type-I and -II subunit mRNAs of activin/BMP receptors are expressed in Pit-1-negative FSH-producing (FSH-oma) and nonfunctioning pituitary adenomas (NF-oma). Basal levels of serum FSH standardized by luteinizing hormone (LH) were markedly high in FSH-omas in contrast to NF-omas. However, gonadotropin-releasing hormone (GnRH)-induced increment of FSH standardized by that of LH was not changed in FSH-omas, suggesting that imbalanced FSH secretion by FSH-oma is not attributable to GnRH regardless of the expression of GnRH receptor. Although activin βA subunit was detected in neither adenoma, the βB subunit was expressed highly in FSH-omas and, to lesser extent, in NF-omas. As for BMPs, BMP-6 and -7 were detected in NF-omas while BMP-4 and -15 were not detected in either type of adenoma. In the presence of pituitary activin/BMP system, the levels of co-expressing follistatin mRNA in the tumors were reduced in FSH-oma compared with NF-oma, suggesting that endogenous follistatin is involved in FSH overproduction through inhibition of activin/BMP system independently of GnRH.

KW - Activin

KW - Bone morphogenetic protein

KW - Follicle-stimulating hormone

KW - Follistatin

KW - Gonadotropin-releasing hormone

KW - Gonadotropinoma

KW - Luteinizing hormone

KW - Macroadenoma

KW - Pituitary adenoma

UR - http://www.scopus.com/inward/record.url?scp=0038095442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038095442&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(03)01052-0

DO - 10.1016/S0006-291X(03)01052-0

M3 - Article

C2 - 12821114

AN - SCOPUS:0038095442

VL - 306

SP - 812

EP - 818

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -